| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | tendon development | 4.28e-05 | 7 | 30 | 2 | GO:0035989 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.99e-05 | 5 | 30 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.30e-04 | 12 | 30 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.30e-04 | 12 | 30 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 4.11e-04 | 21 | 30 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | basement membrane | 7.02e-04 | 122 | 30 | 3 | GO:0005604 | |
| MousePheno | abnormal costal cartilage morphology | 4.94e-05 | 7 | 22 | 2 | MP:0006432 | |
| Domain | SH3_1 | 1.31e-04 | 164 | 30 | 4 | PF00018 | |
| Domain | NC1_FIB | 1.36e-04 | 11 | 30 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.36e-04 | 11 | 30 | 2 | IPR000885 | |
| Domain | Fib_collagen_C | 1.36e-04 | 11 | 30 | 2 | PD002078 | |
| Domain | COLFI | 1.36e-04 | 11 | 30 | 2 | SM00038 | |
| Domain | COLFI | 1.36e-04 | 11 | 30 | 2 | PF01410 | |
| Domain | SH3_9 | 2.62e-04 | 78 | 30 | 3 | PF14604 | |
| Domain | SH3 | 3.77e-04 | 216 | 30 | 4 | PS50002 | |
| Domain | SH3 | 3.77e-04 | 216 | 30 | 4 | SM00326 | |
| Domain | SH3_domain | 4.04e-04 | 220 | 30 | 4 | IPR001452 | |
| Domain | TSPN | 6.18e-04 | 23 | 30 | 2 | SM00210 | |
| Domain | Laminin_G_2 | 1.87e-03 | 40 | 30 | 2 | PF02210 | |
| Domain | ARM-type_fold | 2.01e-03 | 339 | 30 | 4 | IPR016024 | |
| Domain | LamG | 2.26e-03 | 44 | 30 | 2 | SM00282 | |
| Domain | Laminin_G | 3.90e-03 | 58 | 30 | 2 | IPR001791 | |
| Domain | - | 5.31e-03 | 222 | 30 | 3 | 1.25.10.10 | |
| Domain | HEAT_REPEAT | 5.63e-03 | 70 | 30 | 2 | PS50077 | |
| Domain | Collagen | 8.20e-03 | 85 | 30 | 2 | PF01391 | |
| Domain | Collagen | 8.20e-03 | 85 | 30 | 2 | IPR008160 | |
| Domain | ARM-like | 9.09e-03 | 270 | 30 | 3 | IPR011989 | |
| Domain | - | 1.02e-02 | 95 | 30 | 2 | 2.60.120.200 | |
| Pubmed | Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream. | 7.19e-07 | 2 | 30 | 2 | 11342118 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 34009784 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 2.16e-06 | 3 | 30 | 2 | 9582436 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 36553626 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 4.31e-06 | 4 | 30 | 2 | 17683922 | |
| Pubmed | Aspirin induces platelet receptor shedding via ADAM17 (TACE). | 4.31e-06 | 4 | 30 | 2 | 16179345 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 21467034 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 10722718 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.08e-05 | 6 | 30 | 2 | 17029294 | |
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.08e-05 | 6 | 30 | 2 | 8563024 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 17876790 | ||
| Pubmed | Genetics of platelet reactivity in normal, healthy individuals. | 1.51e-05 | 7 | 30 | 2 | 19740098 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 19132198 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 2.01e-05 | 8 | 30 | 2 | 20059976 | |
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 18816857 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 3.94e-05 | 11 | 30 | 2 | 38303699 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.65e-05 | 86 | 30 | 3 | 28327460 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.98e-05 | 248 | 30 | 4 | 24006456 | |
| Pubmed | 7.50e-05 | 15 | 30 | 2 | 10780854 | ||
| Pubmed | 1.71e-04 | 125 | 30 | 3 | 19019335 | ||
| Pubmed | Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. | 1.84e-04 | 128 | 30 | 3 | 18818748 | |
| Pubmed | Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. | 1.84e-04 | 128 | 30 | 3 | 19527514 | |
| Pubmed | 2.13e-04 | 25 | 30 | 2 | 19180518 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.15e-04 | 135 | 30 | 3 | 28675934 | |
| Pubmed | 2.88e-04 | 29 | 30 | 2 | 22613833 | ||
| Pubmed | 3.51e-04 | 32 | 30 | 2 | 23154389 | ||
| Pubmed | 3.83e-04 | 403 | 30 | 4 | 35253629 | ||
| Pubmed | 4.60e-04 | 175 | 30 | 3 | 28071719 | ||
| Pubmed | 5.49e-04 | 186 | 30 | 3 | 20452482 | ||
| Pubmed | 5.49e-04 | 186 | 30 | 3 | 20673868 | ||
| Pubmed | 8.25e-04 | 214 | 30 | 3 | 22199357 | ||
| Pubmed | 8.59e-04 | 50 | 30 | 2 | 23658023 | ||
| Cytoband | 14q12 | 6.00e-04 | 55 | 30 | 2 | 14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q12 | 2.16e-03 | 105 | 30 | 2 | chr14q12 | |
| GeneFamily | Collagens | 4.85e-04 | 46 | 13 | 2 | 490 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 5.38e-05 | 64 | 30 | 3 | M2572 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN | 7.42e-05 | 198 | 30 | 4 | M4603 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 7.57e-05 | 199 | 30 | 4 | M9001 | |
| Coexpression | GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 7.72e-05 | 200 | 30 | 4 | M5124 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.41e-06 | 194 | 30 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.67e-05 | 123 | 30 | 3 | 064e272ee307af0b3f85bb8bafe7f0195ddc3d52 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.67e-05 | 123 | 30 | 3 | 977d91f95c63996cbc1eb9280e12bb55c8b452c8 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-05 | 134 | 30 | 3 | 92981dc68c1b3cdc53f9cf83386c47f0c6c98ae7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-04 | 151 | 30 | 3 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-04 | 151 | 30 | 3 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 153 | 30 | 3 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 166 | 30 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 166 | 30 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.89e-04 | 167 | 30 | 3 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 168 | 30 | 3 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 168 | 30 | 3 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 169 | 30 | 3 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 169 | 30 | 3 | 3ad534303b4b60a77d171e605a1ba2ef20b5e2a3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 169 | 30 | 3 | 29dca061864c86218ab73a86cf6e3c522472da47 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 169 | 30 | 3 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 169 | 30 | 3 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.00e-04 | 170 | 30 | 3 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 171 | 30 | 3 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-04 | 173 | 30 | 3 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-04 | 174 | 30 | 3 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-04 | 175 | 30 | 3 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.21e-04 | 176 | 30 | 3 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 177 | 30 | 3 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 179 | 30 | 3 | 5ccf0824611ded5c673d94dff3048aedac12f1a8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 180 | 30 | 3 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 30 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 181 | 30 | 3 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 181 | 30 | 3 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 183 | 30 | 3 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 185 | 30 | 3 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.56e-04 | 185 | 30 | 3 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 30 | 3 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | Control-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.60e-04 | 186 | 30 | 3 | a8a4c0f4058f5bbc435dd2dd41d55383173a1358 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 30 | 3 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Mega-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 2.68e-04 | 188 | 30 | 3 | 8e80e0714883e5c5e372d933682c5b55ebef7e62 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-CTL|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.72e-04 | 189 | 30 | 3 | 8a02c40bfc92cee37c4dee7c7bf98ab826f64a14 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.72e-04 | 189 | 30 | 3 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | tumor_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.77e-04 | 190 | 30 | 3 | e3ba8d36e0ad9525912b1891922573b55a1d5ed9 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 190 | 30 | 3 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.81e-04 | 191 | 30 | 3 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-04 | 191 | 30 | 3 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 192 | 30 | 3 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.85e-04 | 192 | 30 | 3 | 189477c44040cf0ee16c3932fa49fbd9e3acaa3c | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 2.85e-04 | 192 | 30 | 3 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 193 | 30 | 3 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 193 | 30 | 3 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.90e-04 | 193 | 30 | 3 | 47249aabdd912052aa635d276eed20d32b525393 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 193 | 30 | 3 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 194 | 30 | 3 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 194 | 30 | 3 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 194 | 30 | 3 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_2|COVID-19_Severe / Disease condition and Cell class | 2.94e-04 | 194 | 30 | 3 | 9a9dd34c2e1da1c67c3d9ba99b329966cb9f41d1 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 2.99e-04 | 195 | 30 | 3 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | MS-granulo1|MS / Condition, Cell_class and T cell subcluster | 2.99e-04 | 195 | 30 | 3 | 29688f55a6cdefbff4e818c20cb89473fbc16a59 | |
| ToppCell | MS-granulo1-|MS / Condition, Cell_class and T cell subcluster | 2.99e-04 | 195 | 30 | 3 | eeaa2ecbcfbfb203c77261367b43ce55e786b312 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-04 | 195 | 30 | 3 | eb96439b59914954f684c4bfd9e9a6dbd3201a20 | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 2.99e-04 | 195 | 30 | 3 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 2.99e-04 | 195 | 30 | 3 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / disease group, cell group and cell class | 3.03e-04 | 196 | 30 | 3 | 1bc1ec3351319c5d2daa0808cf161a7327e1758e | |
| ToppCell | COVID-19_Severe-NK|World / disease group, cell group and cell class | 3.03e-04 | 196 | 30 | 3 | f46ca7cc2d8407d0dcaa77c4b16a2c1f2a23734d | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 197 | 30 | 3 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 3.08e-04 | 197 | 30 | 3 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.08e-04 | 197 | 30 | 3 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.08e-04 | 197 | 30 | 3 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 197 | 30 | 3 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 3.08e-04 | 197 | 30 | 3 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 3.08e-04 | 197 | 30 | 3 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.08e-04 | 197 | 30 | 3 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | eb07545bef5ad506fbbe3a1f99131f26c1447a31 | |
| ToppCell | Tracheal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-04 | 197 | 30 | 3 | e91572edbe48d40269ee2cf7c858764cff6985ac | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 197 | 30 | 3 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-04 | 197 | 30 | 3 | 7e3f78a61089d1200cc6b0fa2034bf2998651694 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | LAM-Endothelial-VasEndo-2|Endothelial / Condition, Lineage and Cell class | 3.12e-04 | 198 | 30 | 3 | 92bccaec01f1dbb17d5efcba30f7f800f674ca96 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 198 | 30 | 3 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 198 | 30 | 3 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 30 | 3 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.12e-04 | 198 | 30 | 3 | 72dc49aa107d0cc6206eb67b577c73e190855125 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 30 | 3 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 198 | 30 | 3 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.12e-04 | 198 | 30 | 3 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.12e-04 | 198 | 30 | 3 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.12e-04 | 198 | 30 | 3 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.12e-04 | 198 | 30 | 3 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 30 | 3 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | (2)_NK/T|World / immune cells in Peripheral Blood (logTPM normalization) | 3.12e-04 | 198 | 30 | 3 | 3156d26d9a153f594e140cdb04c55b9527747ef0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.17e-04 | 199 | 30 | 3 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.17e-04 | 199 | 30 | 3 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-04 | 199 | 30 | 3 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.15e-06 | 189 | 28 | 5 | CID000001413 | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.95e-06 | 198 | 28 | 5 | 3276_UP | |
| Drug | Y-27632 | 1.39e-05 | 444 | 28 | 6 | CID000005711 | |
| Drug | BPAT-143 | 2.18e-05 | 6 | 28 | 2 | CID000146249 | |
| Drug | d-indobufen | 3.14e-05 | 50 | 28 | 3 | CID000044562 | |
| Drug | bromfenac | 4.07e-05 | 8 | 28 | 2 | CID000060726 | |
| Drug | AC1L18QD | 4.31e-05 | 325 | 28 | 5 | CID000000213 | |
| Drug | 4-aminoazobenzene | 7.24e-05 | 66 | 28 | 3 | CID000006051 | |
| Drug | TZI-41127 | 7.97e-05 | 11 | 28 | 2 | CID000128480 | |
| Drug | 7-(1-imidazolyl)heptanoic acid | 7.97e-05 | 11 | 28 | 2 | CID000173117 | |
| Drug | foscarnet | 8.22e-05 | 190 | 28 | 4 | CID000003414 | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 3269_UP | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 4972_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 1650_UP | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 6091_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 4277_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 5463_DN | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 5399_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 7280_UP | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 1.00e-04 | 200 | 28 | 4 | 1592_DN | |
| Drug | AC1NMZ1B | 1.06e-04 | 75 | 28 | 3 | CID005034185 | |
| Drug | AC1L9DDB | 1.52e-04 | 15 | 28 | 2 | CID000442763 | |
| Drug | hypoxoside | 1.52e-04 | 15 | 28 | 2 | CID006438448 | |
| Drug | Azlaire | 1.73e-04 | 16 | 28 | 2 | CID000115100 | |
| Drug | 12R-HETrE | 1.73e-04 | 16 | 28 | 2 | CID005283149 | |
| Disease | nephrotic syndrome (is_marker_for) | 1.41e-04 | 18 | 29 | 2 | DOID:1184 (is_marker_for) | |
| Disease | Ovarian Cysts | 5.44e-04 | 35 | 29 | 2 | C0029927 | |
| Disease | Corpus Luteum Cyst | 5.44e-04 | 35 | 29 | 2 | C0010093 | |
| Disease | Liver Cirrhosis, Experimental | 8.63e-04 | 774 | 29 | 5 | C0023893 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.25e-03 | 53 | 29 | 2 | C4707243 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.44e-03 | 57 | 29 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 1.70e-03 | 62 | 29 | 2 | EFO_0803360, EFO_0803362 | |
| Disease | pulse pressure measurement | 2.03e-03 | 1392 | 29 | 6 | EFO_0005763 | |
| Disease | longevity | 2.68e-03 | 284 | 29 | 3 | EFO_0004300 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGYLEEEEYIEEEEY | 101 | Q5W0A0 | |
| YEYGALTIDGEEYIP | 41 | P22352 | |
| YDEGLPEEEEGITYY | 86 | Q99767 | |
| DPGDIEDYYVGVASD | 31 | O95376 | |
| YEEEEAAVVEYSDPY | 426 | Q9NYB9 | |
| ELYTQEYPEEGQYEG | 136 | Q96EV2 | |
| EQLYDGYDEEYDCPI | 41 | Q9Y3D8 | |
| EEEGEEVVEDRDYYY | 261 | Q06481 | |
| AYEVYYGLTEEEGAV | 451 | Q86U38 | |
| DFEYYGYLDEDDGVI | 156 | Q9ULR0 | |
| GYPDEEYDIVTEDGY | 11 | Q5W064 | |
| EYDIVTEDGYILGLY | 16 | Q5W064 | |
| EDLPYYGGSVEIADY | 466 | Q96KR4 | |
| YAPEDIIEYDYEYGE | 261 | P12107 | |
| EELYGDIDALEFYPG | 491 | P23219 | |
| LDEGRYGVYEDENYE | 236 | O15541 | |
| IPGQVYIEVEYDYEY | 11 | Q8IWW6 | |
| DYYDVNEEEAEYLPG | 316 | Q14112 | |
| EDYVPSGGEYSEDDV | 16 | Q9UEE9 | |
| LEYDPYSIYEKDVEG | 751 | Q86XA9 | |
| YFTYDPYSEEDPDEG | 381 | P14784 | |
| EDVGIGDYDYVPSED | 331 | P20908 | |
| TGVPDEDGYDDEYVL | 736 | Q9UBF2 | |
| PTLGDEGDTDLYDYY | 281 | P07359 | |
| EGDTDLYDYYPEEDT | 286 | P07359 | |
| LYDYYPEEDTEGDKV | 291 | P07359 | |
| GESYEDPPQEEYQEY | 116 | Q16143 | |
| YGIVYYEKDGDESSP | 231 | Q8NEB9 | |
| DEERLGEDEYYQVVY | 21 | Q8WWF1 | |
| DGEEDFYYTELDVGV | 236 | Q9NR83 | |
| LEDEPEEPFYRYYVE | 361 | Q9Y2K1 | |
| GGGPIYYIYEEEEEE | 56 | Q96MF2 | |
| VEYYTEEVVYEEVPG | 11 | P20929 |